On this episode of A&M Conversation With, Managing Director Dr. David Gruber sits down with Managing Director Stuart McLean to discuss the U.S. healthcare delivery system in terms cost, effectiveness and the barriers to the coordinated care delivery system.

Michael O’Dowd, a Managing Director with A&M’s Transaction Advisory Group, Managing Director Jeffrey Klein of the Private Equity Performance Improvement Group and Managing Director Art Ehuan of the Disputes and Investigations Group to discuss cybersecurity during the exit stage and the technical testing that is required to identify vulnerabilities.

Michael O’Dowd, a Managing Director with A&M’s Transaction Advisory Group sits down with Managing Directors Jeffrey Klein of the Private Equity Performance Improvement Group and Art Ehuan of the Disputes and Investigations Group to discuss the importance of assessing cyber during the post-acquisition stage.

Michael O’Dowd, a Managing Director with A&M’s Transaction Advisory Group sits down with Managing Directors Jeffrey Klein of the Private Equity Performance Improvement Group and Art Ehuan of the Disputes and Investigations Group to discuss the importance of assessing cyber during the pre-acquisition stage.

In this podcast episode, Managing Director David Gruber sits down with Managing Director John Cox to discuss the Senate's healthcare reform proposal and address the substance abuse epidemic.

On this episode of A&M Conversation With, Valuation Services, Senior Directors Brent Sloan and Robert Pay discuss the election of accounting alternatives for intangible assets acquired in business combinations and subsequent goodwill impairment testing.

In Part 1 of this podcast series, Corporate Performance Improvement Senior Director Art Hall sits down with John Kiger, Vice President of Technology Risk Management at PHH to discuss rapid change in artificial intelligence (AI) and its role in third party risk management.

Dr. David Gruber sits down with Managing Directors Peter Urbanowicz and John Cox to discuss the House of Representatives AHCA vote that has now moved on to the Senate. What will this mean for the future of healthcare?

Managing Director Peter Urbanowicz discusses the cancelled House of Representatives AHCA vote. What will this mean for repealing and replacing the ACA?

Our last issue focused on the possible impact of the surprise election of President Trump to the Affordable Care Act, colloquially referred to as Obamacare. In the article, A&M graded Obamacare, speculated about the emerging Republican replacement plan, provided fundamental context to the evolving debate and identified impacted stakeholders.